Cargando…
Immunotherapy improves the prognosis of lung cancer: do we have to change intensive care unit admission and triage guidelines?
Autores principales: | Guillon, Antoine, Reckamp, Karen L., Heuzé-Vourc’h, Nathalie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270208/ https://www.ncbi.nlm.nih.gov/pubmed/28126007 http://dx.doi.org/10.1186/s13054-017-1602-8 |
Ejemplares similares
-
Immune Checkpoint and Anti-Angiogenic Antibodies for the Treatment of Non-Small Cell Lung Cancer in the European Union and United States
por: Ferreira, Marion, et al.
Publicado: (2021) -
Compliance with intensive care admission guidelines on triage
por: Choi, GYS, et al.
Publicado: (2002) -
Inhalation of Immuno-Therapeutics/-Prophylactics to Fight Respiratory Tract Infections: An Appropriate Drug at the Right Place!
por: Sécher, Thomas, et al.
Publicado: (2019) -
Alternative Routes of Administration for Therapeutic Antibodies—State of the Art
por: Pitiot, Aubin, et al.
Publicado: (2022) -
Pneumocystis Pneumonia: Pitfalls and Hindrances to Establishing a Reliable Animal Model
por: Chesnay, Adélaïde, et al.
Publicado: (2022)